MY114942A - Method for treatment of chronic bronchitis using indole compounds - Google Patents
Method for treatment of chronic bronchitis using indole compoundsInfo
- Publication number
- MY114942A MY114942A MYPI98001273A MYPI9801273A MY114942A MY 114942 A MY114942 A MY 114942A MY PI98001273 A MYPI98001273 A MY PI98001273A MY PI9801273 A MYPI9801273 A MY PI9801273A MY 114942 A MY114942 A MY 114942A
- Authority
- MY
- Malaysia
- Prior art keywords
- treatment
- chronic bronchitis
- indole compounds
- indole
- compounds
- Prior art date
Links
- 206010006458 Bronchitis chronic Diseases 0.000 title abstract 2
- 206010006451 bronchitis Diseases 0.000 title abstract 2
- 208000007451 chronic bronchitis Diseases 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title 1
- -1 1H-INDOLE-3-GLYOXYLAMIDE COMPOUND Chemical class 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- AWMLDBKLOPNOAR-UHFFFAOYSA-N indole-3-glyoxylamide Natural products C1=CC=C2C(C(=O)C(=O)N)=CNC2=C1 AWMLDBKLOPNOAR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4210197P | 1997-03-26 | 1997-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY114942A true MY114942A (en) | 2003-02-28 |
Family
ID=21920055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI98001273A MY114942A (en) | 1997-03-26 | 1998-03-24 | Method for treatment of chronic bronchitis using indole compounds |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5972988A (https=) |
| EP (1) | EP1007046A4 (https=) |
| JP (1) | JP4347914B2 (https=) |
| AU (1) | AU6771798A (https=) |
| CA (1) | CA2284757A1 (https=) |
| MY (1) | MY114942A (https=) |
| WO (1) | WO1998042343A1 (https=) |
| ZA (1) | ZA982454B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2309135A1 (en) * | 1997-10-27 | 1999-05-06 | Michael Lyle Denney | N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| ES2241178T3 (es) | 1997-10-27 | 2005-10-16 | Eli Lilly And Company | Profarmacos de ester de morlino-n-etilo de inhibidores indolicos de spla 2. |
| CZ302588B6 (cs) * | 1998-04-02 | 2011-07-27 | Ziopharm Oncology, Inc. | Použití N-substituovaného indol-3-glyoxylamidu pro výrobu léciva |
| US6576654B1 (en) * | 1998-09-23 | 2003-06-10 | Eli Lilly And Company | Method for the treatment of cystic fibrosis |
| US6274578B1 (en) | 1999-04-20 | 2001-08-14 | Eli Lilly And Company | sPLA2 inhibitor ester |
| US6140327A (en) * | 1999-05-12 | 2000-10-31 | Eli Lilly And Company | Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor |
| AU2252201A (en) * | 1999-12-16 | 2001-06-25 | Eli Lilly And Company | Carbon monoxide-based synthesis of spla2 inhibitors |
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| WO2001081306A2 (en) * | 2000-04-19 | 2001-11-01 | Eli Lilly And Company | Azide cyclization-based synthesis and intermediates for spla2 inhibitors |
| MXPA05004121A (es) * | 2002-10-18 | 2006-02-17 | Molichem Medicines Inc | Metodos para tratar la enfermedad de ojo reseco con lantibioticos. |
| JP2006518738A (ja) * | 2003-02-12 | 2006-08-17 | トランス テック ファーマ，インコーポレイテッド | 治療薬としての置換アゾール誘導体 |
| CA2565545A1 (en) * | 2004-05-06 | 2005-12-08 | Molichem Medicines, Inc. | Treatment of ocular diseases and disorders using lantibiotic compositions |
| US7326683B2 (en) * | 2004-05-06 | 2008-02-05 | Molichem Medicines, Inc. | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| US20150338425A1 (en) * | 2011-11-14 | 2015-11-26 | The Brigham And Women's Hospital, Inc. | Treatment and prognosis of lymphangioleiomyomatosis |
| WO2014137978A1 (en) | 2013-03-04 | 2014-09-12 | The Brigham And Women's Hospital, Inc. | Treatment of lymphangioleiomyomatosis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9501404A (pt) * | 1994-04-01 | 1996-03-05 | Lilly Co Eli | 1H-indol-3 glioxilamida e formulação farmacèutica |
-
1998
- 1998-03-12 US US09/042,686 patent/US5972988A/en not_active Expired - Lifetime
- 1998-03-23 ZA ZA9802454A patent/ZA982454B/xx unknown
- 1998-03-24 CA CA002284757A patent/CA2284757A1/en not_active Abandoned
- 1998-03-24 EP EP98913085A patent/EP1007046A4/en not_active Withdrawn
- 1998-03-24 MY MYPI98001273A patent/MY114942A/en unknown
- 1998-03-24 AU AU67717/98A patent/AU6771798A/en not_active Abandoned
- 1998-03-24 WO PCT/US1998/005791 patent/WO1998042343A1/en not_active Ceased
- 1998-03-24 JP JP54592598A patent/JP4347914B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4347914B2 (ja) | 2009-10-21 |
| AU6771798A (en) | 1998-10-20 |
| EP1007046A4 (en) | 2000-11-29 |
| CA2284757A1 (en) | 1998-10-01 |
| US5972988A (en) | 1999-10-26 |
| ZA982454B (en) | 1999-09-23 |
| EP1007046A1 (en) | 2000-06-14 |
| WO1998042343A1 (en) | 1998-10-01 |
| JP2001524962A (ja) | 2001-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY114942A (en) | Method for treatment of chronic bronchitis using indole compounds | |
| CA2370030A1 (en) | Sodium channel blocker compositions and the use thereof | |
| AU7321598A (en) | Use of cholinesterase inhibitors to treat disorders of attention | |
| AU696851B2 (en) | Method of treating hyperproliferative vascular disease | |
| AU3713795A (en) | Device for acclimatization to therapy by injections | |
| GEP20022616B (en) | (54) Azepin Derivatives to Inhibiting Farnesyl Protein Transferase and Method for Treatment | |
| GR3026344T3 (en) | Method for treating an lfa-1-mediated disorder. | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| AU1711197A (en) | Method for treating sexual dysfunctions | |
| AU2251901A (en) | Methods and compounds for inhibiting MRP1 | |
| CA2047744A1 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
| GR970100408A (el) | Μεθοδοι προληψεως του καρκινου του μαστου | |
| PL334500A1 (en) | Methods of therapeutically administering substances acting against cd40l | |
| PL342099A1 (en) | Therapeutic agents | |
| IL98574A0 (en) | Piperidyl-substituted indoles | |
| WO2001080813A3 (en) | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy | |
| MX9602905A (es) | Composiciones y metodos que usan el receptor mpl no enlazado para la estimulacion de la produccion de plaquetas. | |
| AU6311498A (en) | Hgf for treating acute renal failure | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| GR3023645T3 (en) | Treatment of liver cancer | |
| TR200003194T2 (tr) | Hastalık tedavisine mahsus sPLA2 önleyici bileşikler | |
| AU4530796A (en) | Treating disorders characterised by excessive cell proliferation with sclareolide | |
| BG103779A (en) | Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid | |
| TR200103526T2 (tr) | Kardiyovaskular hastalıkların terapisi için aminotetralin türevi. | |
| DK0517787T3 (da) | Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide |